Corporate

FINN Partners Wins Global Communications Mandate for Leading Neurodegenerative Disease Research Summit

FINN Partners Wins Global Communications Mandate for Leading Neurodegenerative Disease Research Summit

FINN Partners, one of the fastest-growing independent public relations and marketing agencies in the world, has been appointed global agency of record for the AD/PD™ Conference, the premier international gathering dedicated to advancing scientific breakthroughs in Alzheimer’s disease, Parkinson’s disease, and related neurodegenerative conditions. The appointment positions FINN Partners at the center of a field that commands growing urgency as aging populations across developed economies strain healthcare systems and research budgets alike. As the tech investment landscape increasingly intersects with life sciences, the communications infrastructure surrounding major research conferences has taken on heightened strategic importance.

The AD/PD™ Conference, organized by the non-profit International Conference on Alzheimer’s and Parkinson’s Diseases, draws thousands of leading researchers, clinicians, and industry stakeholders annually. The 2025 edition attracted more than 7,000 attendees from over 70 countries, underscoring the event’s standing as a critical venue for unveiling clinical trial data, emerging therapies, and policy discussions that often move pharmaceutical markets. According to a PRNewswire announcement, FINN Partners will oversee global media relations, content strategy, digital communications, and stakeholder engagement across the conference’s full portfolio of activities.

A vast modern convention center exhibition hall with empty rows of display booths under bright overhead lighting, set up for a large scientific conference

A High-Stakes Mandate in a Growing Research Sector

Neurodegenerative disease research has emerged as one of the most heavily funded and commercially consequential areas in global medicine. The Alzheimer’s drug market alone is projected to exceed $14 billion annually by the early 2030s, driven in part by the conditional approvals of amyloid-targeting therapies that have revived investor confidence in a therapeutic category once plagued by late-stage trial failures. For a communications agency, winning the AD/PD™ mandate means direct exposure to pharmaceutical companies, biotech firms, academic institutions, and regulatory bodies that collectively represent enormous advertising and sponsorship budgets.

FINN Partners brings a dedicated health practice that spans medical devices, biopharma, and patient advocacy, making it a credible fit for a scientifically rigorous environment. The agency, which has grown substantially through acquisitions over the past decade and now operates across more than 30 offices worldwide, has increasingly positioned its health division as a differentiator in competitive pitches. For the AD/PD™ Conference organizers, the choice of a single coordinated global agency over a patchwork of regional communications firms reflects a broader trend in event management toward unified brand narratives that can travel consistently across languages and regulatory environments.

Strategic Implications for Conference Communications

The scope of the mandate extends well beyond traditional media outreach. FINN Partners will be responsible for managing communications tied to the conference’s scientific program, including abstract presentations, keynote announcements, and live data readouts that can directly influence share prices of publicly traded sponsors and exhibitors. This requires a communications team capable of operating with both scientific literacy and financial market awareness — a combination that is increasingly demanded in health-focused agency work as the line between scientific disclosure and material investor information has narrowed.

A wide-angle view of an empty auditorium stage with a large projection screen displaying molecular imagery, surrounded by tiered seating in a dimly lit conference venue

The appointment also reflects confidence in FINN Partners’ ability to manage the logistical complexity of a truly global event. The AD/PD™ Conference alternates venues across Europe and North America, requiring seamless coordination across time zones, languages, and local media landscapes. FINN Partners will need to leverage its international office network to deliver consistent messaging from Vienna and Barcelona to San Diego and beyond. For the agency’s health practice leadership, the win represents a marquee account that reinforces its credibility in an increasingly competitive segment of the communications industry. As construction AI platforms and other technology firms race to embed themselves in professional conference circuits as sponsors and data partners, the communications infrastructure around events like AD/PD™ is itself becoming a commercially strategic asset.

No financial terms of the agency engagement were disclosed. The partnership is expected to begin immediately, with FINN Partners taking a lead role in preparations for the next major AD/PD™ event cycle.

Follow The Fiscalist

Subscribe to The Fiscalist

To receive updates about new articles, or opt in to our daily digest.

Choose one:

We don’t spam! Read our privacy policy for more info.

Subscribe to The Fiscalist

To receive updates about new articles, or opt in to our daily digest.

Choose one:

We don’t spam! Read our privacy policy for more info.